Skip to content

Panchakarma therapy along with herbal decoction used in treatment of Mamsagata vata

An Open Label Comparative Clinical Study On Virechana Karma And Patra Pinda Sweda Followed By Vishwadi Dwadashanga Kwatha In The Management Of Mamsagata Vata W.S.R. To Fibromyalgia - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072730
Enrollment
78
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

None listed

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the clinical features of Mamsagata Vata Patients with the clinical features of Fibromyalgia Patients fit for Virechana Karma Chronicity less than ten years FIQ Score should be less then thirty three

Exclusion criteria

Exclusion criteria: Patient suffering from any chronic debilitating disease like TB Varicose vein Asthma Rheumatoid Arthritis and other chronic problems et cetera and having other serious pathology Patients suffering from systemic disorders as cardiac problem Diabetes Mellitus Hypertension more than 140mmHg Systolic pressure and diastolic pressure more than 90 mmHg Paralysis Malignancy HIV HBsAg Leprosy Pregnant women and lactating mother

Design outcomes

Primary

MeasureTime frame
Any change and improvement present in Mamsagata Vata symptoms of registered patientsTimepoint: 42 weeks

Secondary

MeasureTime frame
Improvement and change present symptoms in fibromyalgia Changes in FIBROMYALGIA IMPACT QUESTIONNAIRE Timepoint: 48 weeks

Countries

India

Contacts

Public ContactDr Govind Narayan

Shri Krishna Ayush University

drashishhmehta@gmail.com8950375285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026